These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1219 related articles for article (PubMed ID: 29328395)

  • 1. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
    Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
    J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses.
    Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q
    J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysis.
    Wu M; Zhao Y; Peng N; Tao Z; Chen B
    Invest New Drugs; 2021 Jun; 39(3):705-712. PubMed ID: 33394259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
    Li Q; Zhang LY; Wu S; Huang C; Liu J; Wang P; Cao Y
    Med Sci Monit; 2019 Oct; 25():7784-7794. PubMed ID: 31621692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of chemoresistance-associated miRNAs in breast cancer.
    Lou W; Liu J; Ding B; Xu L; Fan W
    Cancer Manag Res; 2018; 10():4747-4757. PubMed ID: 30425571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
    Jin X; Guan Y; Zhang Z; Wang H
    BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-derived microRNAs contribute to prostate cancer chemoresistance.
    Li J; Yang X; Guan H; Mizokami A; Keller ET; Xu X; Liu X; Tan J; Hu L; Lu Y; Zhang J
    Int J Oncol; 2016 Aug; 49(2):838-46. PubMed ID: 27278879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of Potential miRNA-mRNA Regulatory Network in COPD Plasma by Bioinformatics Analysis.
    Zhu M; Ye M; Wang J; Ye L; Jin M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2135-2145. PubMed ID: 32982206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.
    Li Y; Li L
    J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis.
    Zhao X; Ren Y; Cui N; Wang X; Cui Y
    Medicine (Baltimore); 2018 Sep; 97(39):e12632. PubMed ID: 30278585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Index of Sensitivity to Chemotherapy for Triple Negative Breast Cancer.
    Sameer C A; Shah M; Nandy D; Gupta R
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):2043-2053. PubMed ID: 37378935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.